C2 and hepatocellular carcinoma: Signaling pathways, such as “AMPK signaling pathway” and “PPAR signaling pathway,” were found to be significantly enriched in HCC patients with higher C2 expression from all three HCC cohorts, which have been reported to take part in the development and progression of HCC.